Danske Bank A S Takes $51.53 Million Position in Agilent Technologies, Inc. $A

Danske Bank A S bought a new position in shares of Agilent Technologies, Inc. (NYSE:A) in the third quarter, according to the company in its most recent filing with the SEC. The firm bought 401,467 shares of the medical research company’s stock, valued at approximately $51,528,000. Danske Bank A S owned approximately 0.14% of Agilent Technologies as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in A. Vanguard Group Inc. boosted its holdings in shares of Agilent Technologies by 1.8% in the 2nd quarter. Vanguard Group Inc. now owns 33,997,845 shares of the medical research company’s stock worth $4,012,086,000 after acquiring an additional 589,219 shares in the last quarter. Wellington Management Group LLP grew its holdings in shares of Agilent Technologies by 4.8% during the third quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company’s stock worth $1,203,990,000 after purchasing an additional 433,342 shares during the last quarter. Generation Investment Management LLP increased its stake in shares of Agilent Technologies by 10.1% in the third quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock valued at $816,043,000 after buying an additional 582,093 shares in the last quarter. Norges Bank bought a new position in shares of Agilent Technologies in the second quarter valued at about $395,088,000. Finally, Ameriprise Financial Inc. lifted its position in Agilent Technologies by 15.1% during the 3rd quarter. Ameriprise Financial Inc. now owns 2,708,591 shares of the medical research company’s stock worth $347,685,000 after buying an additional 354,480 shares in the last quarter.

Agilent Technologies Trading Down 1.2%

NYSE:A opened at $111.41 on Thursday. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59. The stock has a market capitalization of $31.48 billion, a PE ratio of 24.59, a price-to-earnings-growth ratio of 2.37 and a beta of 1.31. The business’s 50-day simple moving average is $128.30 and its 200-day simple moving average is $135.59.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The business had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. During the same period in the previous year, the company posted $1.31 earnings per share. Agilent Technologies’s revenue for the quarter was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Sell-side analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be paid a $0.255 dividend. The ex-dividend date is Tuesday, March 31st. This represents a $1.02 annualized dividend and a yield of 0.9%. Agilent Technologies’s payout ratio is presently 22.52%.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on A. Wells Fargo & Company reduced their target price on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research report on Thursday, February 26th. The Goldman Sachs Group started coverage on Agilent Technologies in a report on Tuesday, December 9th. They issued a “buy” rating and a $170.00 price target on the stock. Evercore raised Agilent Technologies from an “in-line” rating to an “outperform” rating and boosted their price objective for the stock from $155.00 to $160.00 in a report on Monday, January 5th. UBS Group cut their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Agilent Technologies in a report on Monday, December 29th. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $161.20.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.